Efficacy and Safety of Peginterferon Alfa-2b and Ribavirin Therapy in Subjects With Type C Compensated Liver Cirrhosis (Study P05116)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)
- Status
- COMPLETED
- Phase
- PHASE4
Enthesitis With Ultra Sonography Doppler in Spondyloarthropathies Treated With Infliximab (Study P04440)
- Status
- TERMINATED
- Phase
- PHASE4
Efficacy of Peginterferon Alfa-2b (SCH 054031) vs Glycyrrhizin in Interferon (IFN)-Treated Patients With Chronic Hepatitis C and F2/F3 Liver Fibrosis (P04773)
- Status
- TERMINATED
- Phase
- PHASE3
Vicriviroc (SCH 417690) Treatment Protocol in Human Immunodeficiency Virus (HIV)-Infected Participants: A Rollover Study for ACTG Protocol A5211 (P04100)
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603)
- Status
- COMPLETED
- Phase
- PHASE3
Pegylated Interferon (PEG-IFN) Alfa-2b and Low Dose Ribavirin for the Treatment of Chronic Hepatitis C Patients With Genotype 1 High Viral Load and Low Body Weight (Study P05172)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE4
Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)
- Status
- COMPLETED
- Phase
- PHASE4
Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)
- Status
- TERMINATED
- Phase
- PHASE2
Study to Evaluate the Efficacy of Infliximab Induction Therapy for Patients With Palmoplantar Psoriasis (PPP)(Study P04555)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
Single Patient Treatment of Posaconazole in Invasive Fungal Infections (Study P05113)
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
A Study to Evaluate the Switch From Etanercept to Infliximab in Subjects With Moderate-to-Severe Psoriasis (Study P05133)
- Status
- COMPLETED
- Phase
- PHASE4
Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)
- Status
- COMPLETED
- Phase
- PHASE4
Evaluation of Peginterferon Alfa-2b Monotherapy and Combination With Ribavirin in Participants With Acute Hepatitis C (P03552/MK-4031-137)
- Status
- COMPLETED
- Phase
- PHASE3
Study to Assess the Tolerability and Efficacy of Anacetrapib in Patients With Coronary Heart Disease (CHD) or CHD Risk-Equivalent Disease (MK-0859-019)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess the Clinical Effects of Navarixin in Participants With Psoriasis (MK-7123-009)
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide Phase II Clinical Study in Patients With Newly Diagnosed Glioblastoma Multiforme (Study P04661)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE2
Trial to Assess the Safety of Vorapaxar in Japanese Subjects With Cerebral Infarction (P05005; MK-5348-017)
- Status
- COMPLETED
- Phase
- PHASE2
Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE4
Trial to Assess the Safety and Effects of Vorapaxar in Japanese Subjects With Acute Coronary Syndrome (P04772; MK-5348-016)
- Status
- COMPLETED
- Phase
- PHASE2